The Effects of p-nonylphenol on the Myometrial Contractile Activity.


Özatik F. Y., Kaygisiz B., Erol K., Dundar Y., Onkol T., Sahin M. F.

Drug research, vol.65, pp.388-92, 2015 (Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 65
  • Publication Date: 2015
  • Doi Number: 10.1055/s-0034-1387717
  • Journal Name: Drug research
  • Journal Indexes: Scopus
  • Page Numbers: pp.388-92
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

We aimed to investigate the effects and mechanisms of action of p-nonylphenol(p-NP) on uterine contractility in rats. The uterine tissues of female Sprague Dawley rats in diestrus were bathed in isolated organ bath. The effects of vehicle alone (0.1% ethanol), the positive control 17--E-2 (10(-5) M) and p-NP (10(-9) M, 10(-8) M, 10(-7) M, 10(-6) M) on spontaneous and KCl-induced uterine contractility of rats were studied. Also, the effects of p-NP in combination with actinomycin D (10(-5) M) (gene transcription inhibitor), cycloheximide (10(-4) M) (protein synthesis inhibitor), fulvestrant (10(-6) M) (pure estrogen receptor antagonist), 2-hydroxy-5-nonanoylbenzamide (10(-3) M) (compound 1b, anti-uterotrophic compound) on spontaneous uterine contractions, and with propranolol (20 mu M) (-adrenoceptor antagonist) and noradrenaline (5 mu M) on KCl (40mM) induced contractions were investigated. p-NP exhibited a concentration-dependent inhibition on spontaneous uterine contractions. There was no significant difference between the highest p-NP concentration (10(-6) M) and the positive control 17--E-2 in terms of % inhibition (p>0.05). The inhibitory effect of p-NP (10(-6) M) on spontaneous contractions was blocked by actinomycin D (p<0.001), cycloheximide (p<0.001), fulvestrant (p<0.001) and compound 1b (p<0.001). 17--E-2 (10(-5) M) exerted a higher inhibition % on KCl induced contractions than p-NP (10(-6) M). The relaxant effect of p-NP on KCl-induced uterine contractions was inhibited by noradrenaline (p<0.05) but not by propranolol (p>0.05). We suggest that p-NP inhibited uterine contractions similar as 17--E-2 and genomic pathways are involved and -adrenoceptors might modulate the activity of p-NP. In addition, compound 1b showed an uterotonic activity and reversed the effect of p-NP.